APA

United States, . (2017). Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain: hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. Washington: U.S. Government Publishing Office.

Chicago

United States, . 2017. Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain: hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. Washington: U.S. Government Publishing Office.

Harvard

United States, . (2017). Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain: hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. Washington: U.S. Government Publishing Office.

MLA

United States, . Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain: hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. Washington: U.S. Government Publishing Office. 2017.